HGC Investment Management’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-70,425
Closed -$174K 107
2025
Q1
$174K Buy
+70,425
New +$167K 0.06% 44

Other funds holding SLRN

HGC Investment Management's SLRN Position: Q2 2025 in Review

HGC Investment Management sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 70,425 shares — an estimated $174K sold.

HGC Investment Management first reported a position in SLRN in Q1 2025 and held it in 1 quarter. The position peaked at $174K in Q1 2025. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • HGC Investment Management reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • HGC Investment Management sold 70,425 ACELYRIN shares in Q2 2025, an estimated $174K.
  • HGC Investment Management first reported a position in ACELYRIN in Q1 2025 and held it in 1 quarter.
  • HGC Investment Management's ACELYRIN position peaked at $174K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on HGC Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.